Healthcare Triangle Business Summary

Healthcare Triangle, Inc. (HCTI) is a digital transformation leader specializing in cloud services, data science, and managed services for the highly regulated healthcare and life sciences sectors. The company generates revenue through a diversified mix of subscription-based SaaS licensing for its proprietary platforms (CloudEz, DataEz, and Readabl.AI), consumption-based fees via its Ezovion electronic medical record (EMR) platform, and professional service fees for strategic advisory and implementation. HCTI operates through three primary business segments: Software Services, Managed Services and Support, and Platform Services. In early 2026, the company significantly expanded its market footprint by acquiring Spanish AI firms Teyame 360 and Datono Mediacion, integrating omnichannel AI customer experience tools into its healthcare ecosystem. HCTI competes directly with players such as True North, BlueNovo, and XIAO-I (AIXI), positioning itself as a specialized, small-cap niche partner for organizations requiring deep domain expertise in HIPAA-compliant cloud infrastructure and data democratization. Healthcare Triangle was formed in June 2020 through the strategic integration of the "born-in-the-cloud" firm 8K Miles and the health IT consultancy Cornerstone Advisors. The leadership team is anchored by Founder, Chairman, and CEO Suresh Venkatachari, a veteran entrepreneur with over three decades of experience in technology and healthcare. Key executives include Chief Operating Officer Sujatha Ramesh, who brings over 25 years of operational expertise and holds an MBA from NYU’s Stern School of Business, and Chief Financial Officer David Ayanoglou, a CPA and Chartered Business Valuator appointed in 2025 to oversee global financial strategy. The executive team is further supported by Co-Founder and Head of Strategy Lakshmanan Kannappan and Board Chairman Dave Rosa. While institutional ownership remains concentrated at approximately 0.33%, notable shareholders include XTX Topco Ltd, Jane Street Group, and The Vanguard Group, reflecting a specialized base of institutional interest in the company’s AI-driven growth trajectory.